bnf for children 2011 2012 british national formulary for children
BNF for Children 2011-2012 (British National Formulary for Children)
$145.00 Original price was: $145.00.$4.99Current price is: $4.99. Add to cart
Sale!

BNF for Children 2011-2012 (British National Formulary for Children)

Original price was: $145.00.Current price is: $4.99.

-97%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Pediatric Prescribing Standard: BNF for Children 2011-2012

In pediatric medicine, a single decimal point error in a prescription can be catastrophic. Children undergo rapid physiological changes that fundamentally alter drug metabolism, rendering adult dosing guidelines completely useless. BNF for Children 2011-2012 (British National Formulary for Children) is the definitive, historically critical, and uncompromising clinical formulary that set the standard for pediatric pharmacology in the United Kingdom. This volume provides the absolute blueprints required to prescribe medications safely and effectively to patients ranging from premature neonates to adolescents.

Uncompromising Safety in Pediatric Pharmacology

The core philosophy of this text is absolute prescribing accuracy. The authors aggressively deconstruct the pediatric formulary. They do not rely on generic “rules of thumb”; they provide the exact, rigid, evidence-based dosing regimens for thousands of medications. Every entry is meticulously scrutinized to ensure that the dosages reflect the absolute highest standard of pediatric pharmacological safety.

Navigating Complex Weight-Based Dosing Algorithms

The book provides a masterclass in precise calculation. It dictates the exact algorithms for weight-based and body-surface-area (BSA)-based dosing. It details precisely how to adjust medications for children at extreme ends of the weight spectrum, ensuring therapeutic efficacy while actively preventing devastating toxicological overdoses in highly potent medications.

Managing Rare Side Effects and High-Risk Drug Interactions

This is a fiercely practical guide to medication safety. The authors provide exhaustive details on the unique adverse effect profiles seen in children. The text dictates exactly how to monitor for complex drug-drug interactions, specifically detailing the contraindications for prescribing certain medications in the context of concurrent pediatric illnesses or specific metabolic deficiencies.

Formulating Safe Intravenous and Neonatal Regimens

The final value of this reference is its authority in complex inpatient scenarios. The text provides the exact prescribing blueprints for the most vulnerable populations. It dictates the strict protocols for formulating complex intravenous (IV) infusions, calculating neonatal parenteral nutrition, and managing off-label prescribing—a common necessity in pediatric practice that requires rigorous, evidence-based justification.

Frequently Asked Questions (FAQs)

Does this book cover dosing adjustments for renal and hepatic failure?
Yes, it features massive, critical sections detailing the exact dosage modifications required when a child’s clearance mechanisms are severely compromised, preventing catastrophic drug accumulation.

Is this edition still relevant for modern clinical practice?
While clinicians must always consult the most current BNF for active prescribing, this specific historical edition is invaluable for academic research, analyzing the evolution of pediatric pharmacology, and understanding the foundation of modern dosing guidelines.

Who is the primary audience?
It is an essential reference text for Medical Historians, Pharmacologists, Academic Pediatricians, and Medical Libraries tracking the evolution of therapeutic standards.

Conclusion

BNF for Children 2011-2012 proves that pediatric prescribing is a highly specialized discipline requiring extreme precision and authoritative data. It represents a critical milestone in pediatric patient safety. By reviewing the exhaustive dosing protocols, the safety warnings, and the pharmacological frameworks detailed in this volume, researchers and clinicians gain a profound understanding of the rigid standards that govern pediatric medicine.